Skip to main content

Table 2 Maximum tolerated dose

From: Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

Level

Dose

Number treated

Number of DLTs

Probability of DLT

1

3 × 8 Gy

4

0

0.05

2

3 × 10 Gy

1

0

0.08

3

3 × 12 Gy

8

1

0.11